×
About 87,438 results

ALLMedicine™ Dementia Center

Research & Reviews  30,073 results

Alzheimer’s Biomarkers, Explained
https://www.alzdiscovery.org/news-room/blog/alzheimers-biomarkers-explained
Alzheimer's Matters Blog; Alzheimer's Drug Discovery Foundation

Developing new biomarkers is a priority for the Alzheimer’s Drug Discovery Foundation (ADDF). These tools are critical to the success of our mission to find effective ways to prevent and treat Alzheimer’s disease and other types of dementia.

What Do We Know About Diet and Prevention of Alzheimer's Disease?
https://www.nia.nih.gov/health/what-do-we-know-about-diet-and-prevention-alzheimers-disease
National Institute on Aging

Can eating a specific food or following a particular diet help prevent or delay dementia caused by Alzheimer’s disease? Many studies suggest that what we eat affects the aging brain’s ability to think and remember. These findings have led to resea...

Aortic Stiffness, Pulse Pressure, and Cerebral Pulsatility Progress Despite Best Medica...
https://doi.org/10.1161/STROKEAHA.121.035560
Stroke Webb AJS, Lawson A et. al.

Dec 3rd, 2021 - Increased cerebral arterial pulsatility is associated with cerebral small vessel disease, recurrent stroke, and dementia despite the best medical treatment. However, no study has identified the rates and determinants of progression of arterial sti...

Combining current knowledge on DNA methylation-based age estimation towards the develop...
https://doi.org/10.1016/j.fsigen.2021.102637
Forensic Science International. Genetics; Aliferi A, Sundaram S et. al.

Dec 3rd, 2021 - The estimation of chronological age from biological fluids has been an important quest for forensic scientists worldwide, with recent approaches exploiting the variability of DNA methylation patterns with age in order to develop the next generatio...

see more →

Guidelines  34 results

Alzheimer’s Biomarkers, Explained
https://www.alzdiscovery.org/news-room/blog/alzheimers-biomarkers-explained
Alzheimer's Matters Blog; Alzheimer's Drug Discovery Foundation

Developing new biomarkers is a priority for the Alzheimer’s Drug Discovery Foundation (ADDF). These tools are critical to the success of our mission to find effective ways to prevent and treat Alzheimer’s disease and other types of dementia.

What Do We Know About Diet and Prevention of Alzheimer's Disease?
https://www.nia.nih.gov/health/what-do-we-know-about-diet-and-prevention-alzheimers-disease
National Institute on Aging

Can eating a specific food or following a particular diet help prevent or delay dementia caused by Alzheimer’s disease? Many studies suggest that what we eat affects the aging brain’s ability to think and remember. These findings have led to resea...

International Practice Recommendations for the Recognition and Management of Hearing an...
https://doi.org/10.1159/000515892
Gerontology Littlejohn J, Bowen M et. al.

Jun 7th, 2021 - Hearing, vision, and cognitive impairment commonly co-occur in older people. However, the rate of recognition and appropriate management of combined hearing and vision impairment in people with dementia impairment is low. The aim of this work was ...

Medical Care of Adults With Down Syndrome: A Clinical Guideline.
https://doi.org/10.1001/jama.2020.17024
JAMA Tsou AY, Bulova P et. al.

Oct 21st, 2020 - Down syndrome is the most common chromosomal condition, and average life expectancy has increased substantially, from 25 years in 1983 to 60 years in 2020. Despite the unique clinical comorbidities among adults with Down syndrome, there are no cli...

Recommendations of the 5th Canadian Consensus Conference on the diagnosis and treatment...
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7984031
Alzheimer's & Dementia : the Journal of the Alzheimer's A... Ismail Z, Black SE et. al.

Jul 30th, 2020 - Since 1989, four Canadian Consensus Conferences on the Diagnosis and Treatment of Dementia (CCCDTD) have provided evidence-based dementia guidelines for Canadian clinicians and researchers. We present the results of the 5th CCCDTD, which convened ...

see more →

Drugs  319 results see all →

Clinicaltrials.gov  899 results

Alzheimer’s Biomarkers, Explained
https://www.alzdiscovery.org/news-room/blog/alzheimers-biomarkers-explained
Alzheimer's Matters Blog; Alzheimer's Drug Discovery Foundation

Developing new biomarkers is a priority for the Alzheimer’s Drug Discovery Foundation (ADDF). These tools are critical to the success of our mission to find effective ways to prevent and treat Alzheimer’s disease and other types of dementia.

What Do We Know About Diet and Prevention of Alzheimer's Disease?
https://www.nia.nih.gov/health/what-do-we-know-about-diet-and-prevention-alzheimers-disease
National Institute on Aging

Can eating a specific food or following a particular diet help prevent or delay dementia caused by Alzheimer’s disease? Many studies suggest that what we eat affects the aging brain’s ability to think and remember. These findings have led to resea...

Validation of a Novel Self-Administered Cognitive Assessment Tool (CogCheck) in Patients With Mild and Major Neurocognitive Disorder Predominantly Due to Alzheimer's Disease
https://clinicaltrials.gov/ct2/show/NCT03672279

Nov 25th, 2021 - Due to the demographical development, age-related diseases will drastically increase over the next decades. To face this healthcare challenge, early and accurate identification of cognitive impairment is crucial. The assessment of neurocognitive f...

Natural History Study of CADASIL
https://clinicaltrials.gov/ct2/show/NCT05072483

Nov 25th, 2021 - Small vessel diseases are conditions characterized by the narrowing of small arteries leading to an imbalance of blood supply upon demand. This results in a progressive chronic hypoperfusion with detrimental outcomes for the affected organ system ...

A Study of E2027 in Participants With Dementia With Lewy Bodies (DLB) or Parkinson's Disease Dementia (PDD) With or Without Amyloid Copathology
https://clinicaltrials.gov/ct2/show/NCT04764669

Nov 24th, 2021 - The purpose of study is to demonstrate the pharmacodynamic (PD) effects of E2027 on cerebrospinal fluid (CSF) cyclic guanosine monophosphate (cGMP) in participants with DLB and PDD with and without amyloid copathology after 9 weeks of treatment.

see more →

News  3,592 results

Alzheimer’s Biomarkers, Explained
https://www.alzdiscovery.org/news-room/blog/alzheimers-biomarkers-explained
Alzheimer's Matters Blog; Alzheimer's Drug Discovery Foundation

Developing new biomarkers is a priority for the Alzheimer’s Drug Discovery Foundation (ADDF). These tools are critical to the success of our mission to find effective ways to prevent and treat Alzheimer’s disease and other types of dementia.

What Do We Know About Diet and Prevention of Alzheimer's Disease?
https://www.nia.nih.gov/health/what-do-we-know-about-diet-and-prevention-alzheimers-disease
National Institute on Aging

Can eating a specific food or following a particular diet help prevent or delay dementia caused by Alzheimer’s disease? Many studies suggest that what we eat affects the aging brain’s ability to think and remember. These findings have led to resea...

Coffee and Cognitive Decline; Head Impact Injuries; Alzheimer's Gene Therapy?
https://www.medpagetoday.com/neurology/generalneurology/95927

Nov 30th, 2021 - Higher coffee consumption was tied to slower cognitive decline and less cerebral amyloid-beta accumulation over 126 months, an Australian study showed. (Frontiers in Aging Neuroscience) Physical activity may promote synaptic and cognitive resilien...

New Gambling Disorders Guideline; Wrong Man Held at Psych Hospital; Sad Social Media
https://www.medpagetoday.com/psychiatry/generalpsychiatry/95858

Nov 24th, 2021 - The American Psychiatric Association released a new edition of the clinical treatment guide for gambling disorders, as more and more people are turning to internet betting. A ProPublica investigation uncovered a possible sexual assault of a patien...

Brain Inflammation Seen in Four of 10 Alzheimer's Aducanumab Patients
https://www.medpagetoday.com/neurology/alzheimersdisease/95801

Nov 22nd, 2021 - Brain inflammation known as amyloid-related imaging abnormalities (ARIA) occurred in about 40% of people with early Alzheimer's disease in the two phase III studies of aducanumab (Aduhelm), a secondary analysis of trial data showed. In an integrat...

see more →

Patient Education  58 results see all →